Pretty well done - especially the experimental validation. The main conclusions are accurate, but there is some BS around the periphery. A few notes below.

- The secret sauce here was the large, high quality experimental dataset they generated.

- Chemprop is meh.

- Is a tanimoto similarity < 0.3 really dissimilar? Depends on the chemical fingerprint parameters they are using in RDkit. For ECFP4 the expected similarity of two random molecules is about 0.1. A value of 0.3 about the cutoff you would use for a similarity based virtual screening with ECFP4 fingerprints.

- The cheminformatic filtering steps that they did on their hits was well done.

- The experimental validation of the target was well done. A good illustration of all the preclinical work it takes to validate a molecule and mechanism on the way to an IND.

- They got very lucky. Most of the time your compound hits are not all that potent and require extensive med chem optimization. That was not the case here.